Healthcare & Lifesciences
Is India finally reaching a turning point in cervical cancer prevention?
11 Feb 2026
India’s HPV vaccine market reached ?91 Cr. in early 2026, marking a significant revival in preventive healthcare. While digital platforms have eased access for urban women aged 26–35, the high cost of doses—ranging from ?1.5K to ?11K—remains a barrier. Experts suggest that true scale requires the inclusion of vaccines in national immunization programs to bridge the urban-rural divide.

Read more at Mint

Ready to talk?

I want to talk to your experts in:

We work with ambitious leaders and transformative clients who are defining the future. Together, we achieve extraordinary outcomes.

I have read the privacy policy and I agree to its terms.